ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,052.00
-2.03%
다우존스 지수
43,428.02
-1.69%
Bitcoin
95,744.37
-2.62%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE

  6. Solventum Corporation (SOLV) 시세

Solventum Corporation

Solventum Corporation (SOLV)

SolVBL Solutions Inc
Solvac SA
73.02
-1.48
(-1.99%)
종가: 22 2월 6:00AM
15분 지연
73.02
0.00
( 0.00% )
시간외 거래: 7:30AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
73.02
매수가
-
매도가
-
거래량
570,687
72.41 일간 변동폭 74.72
47.16 52주 범위 77.17
market_cap
12.615B
전일 종가
74.50
개장가
74.47
최근 거래 시간
68
@
73.02
마지막 거래 시간
06:20:00
재정 규모
US$ 41,968,214
VWAP
73.5398
평균 볼륨(3m)
856,000
발행 주식
172,754,070
배당수익률
-
주가수익률
18.23
주당순이익(EPS)
4.01
매출
8.24B
순이익
692M

Solventum Corporation 정보

Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symboliz... Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
www.solventum.com
본부
Wilmington, Delaware, USA
설립됨
-
Solventum Corporation is listed in the Surgical,med Instr,apparatus sector of the 뉴욕 증권거래소 with ticker SOLV. The last closing price for Solventum was US$74.50. Over the last year, Solventum shares have traded in a share price range of US$ 47.16 to US$ 77.17.

Solventum currently has 172,754,070 shares in issue. The market capitalisation of Solventum is US$12.87 billion. Solventum has a price to earnings ratio (PE ratio) of 18.23.

Solventum (SOLV) 옵션 플로우 요약

전체 옵션 플로우 보기

전체 흐름

강세

순 프리미엄

94k

Calls / Puts

100.00%

매수 / 매도

100.00%

OTM / ITM

100.00%

Sweeps 비율

0.00%

SOLV 최신 뉴스

추가 뉴스

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
18 12월 2024
SOLV (-1.99%)

Form POS AM - Post-Effective amendments for registration statement
Edgar (US Regulatory)
12 12월 2024
SOLV (-1.99%)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Edgar (US Regulatory)
11 12월 2024
SOLV (-1.99%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 12월 2024
SOLV (-1.99%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
04 12월 2024
SOLV (-1.99%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.72-2.301311212274.7475.192373.0282108974.26948397CS
4-0.22-0.30038230475273.2476.872.2776309474.37343242CS
120.380.52312775330472.6476.865.42585600071.04336186CS
2613.4422.557905337459.5877.1758.7699723169.79491453CS
523.875.5965292841669.1577.1747.16147676863.88303878CS
1563.875.5965292841669.1577.1747.16147676863.88303878CS
2603.875.5965292841669.1577.1747.16147676863.88303878CS

SOLV - Frequently Asked Questions (FAQ)

What is the current Solventum share price?
The current share price of Solventum is US$ 73.02
How many Solventum shares are in issue?
Solventum has 172,754,070 shares in issue
What is the market cap of Solventum?
The market capitalisation of Solventum is USD 12.87B
What is the 1 year trading range for Solventum share price?
Solventum has traded in the range of US$ 47.16 to US$ 77.17 during the past year
What is the PE ratio of Solventum?
The price to earnings ratio of Solventum is 18.23
What is the cash to sales ratio of Solventum?
The cash to sales ratio of Solventum is 1.53
What is the reporting currency for Solventum?
Solventum reports financial results in USD
What is the latest annual turnover for Solventum?
The latest annual turnover of Solventum is USD 8.24B
What is the latest annual profit for Solventum?
The latest annual profit of Solventum is USD 692M
What is the registered address of Solventum?
The registered address for Solventum is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Solventum website address?
The website address for Solventum is www.solventum.com
Which industry sector does Solventum operate in?
Solventum operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
GENIGenius Sports Limited
US$ 9.7575
(7.23%)
1.99k
BTCMBit Mining Limited
US$ 2.3287
(5.85%)
428
BKSYBlackSky Technology Inc
US$ 17.613
(5.59%)
15.06k
SSTKShutterstock Inc
US$ 26.69
(5.04%)
9.46k
TKOTko Group Holdings Inc
US$ 166.76
(5.00%)
15.45k
PNSTPinstripes Holdings Inc
US$ 0.295
(-7.67%)
19.57k
XPOFXponential Fitness Inc
US$ 14.87
(-5.17%)
583
UTIUniversal Technical Institute Inc
US$ 25.40
(-4.15%)
1.74k
HEHawaiian Electric Industries
US$ 10.3501
(-3.81%)
186.06k
AMRCAmeresco Inc
US$ 18.00
(-3.69%)
5.3k
PSXPhillips 66
US$ 128.78
(0.00%)
4.98M
TAT&T Inc
US$ 26.62
(0.00%)
4.24M
TACTransAlta Corporation
US$ 10.90
(0.00%)
3.15M
BACBank of America Corporation
US$ 44.83
(0.04%)
2.29M
NCLHNorwegian Cruise Line Holdings Ltd
US$ 24.16
(0.21%)
2.04M

SOLV Discussion

게시물 보기
DewDiligence DewDiligence 3 월 전
SOLV 3Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 57% +1%
Dental 15% -4%
Health-info systems 16% +2%
Purification/filtration 11% 0% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 3 월 전
SOLV reports 3Q24 results—raises 2024 guidance…

New 2024 guidance is as follows:

• Non-GAAP EPS of $6.50-6.65 (vs prior guidance of $6.30-6.50).

• Organic sales growth of 0.5-1.0% (vs prior guidance of 0-1%).

• FCF of $750-850M (vs prior guidance of $700-800M).

At the current share price (~$77 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 11.7x.


PR:
https://investors.solventum.com/image/2024-11-07-Solventum-Reports-Third-Quarter-2024-Financial-Results-and-Raises-Full-Year-Guidance.pdf

CC slides:
https://investors.solventum.com/image/SOLV+Q3+2024+Earnings+Presentation.pdf
👍️0
DewDiligence DewDiligence 4 월 전
SOLV seeking buyer for filtration business, according to WSJ sources:

https://www.wsj.com/business/deals/recent-3m-spinoff-explores-sale-of-filtration-unit-f331a83d

In 2Q24, the filtration segment comprised 12% of SOLV’s sales, but the growth rate was non-existent (#msg-174889792).
👍️0
DewDiligence DewDiligence 4 월 전
SOLV hires CMO:

https://finance.yahoo.com/news/solventum-names-surgeon-diagnostics-pioneer-130000072.html
👍️0
DewDiligence DewDiligence 6 월 전
SOLV 2Q24 CC slides:

https://investors.solventum.com/image/Q2+2024+Earnings+Presentation+-+FINAL+8.8.24.pdf
👍️0
DewDiligence DewDiligence 6 월 전
SOLV 2Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales Organic Sales†
Medical/surgical* 56% +2%
Dental 16% -2%
Health-info systems 16% +4%
Purification/filtration 12% -1% †Excludes acquisitions, divestitures, and currency.

*Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 6 월 전
SOLV’s raised 2024 guidance is as follows:

https://finance.yahoo.com/news/solventum-reports-second-quarter-2024-200500242.html

• 2024 organic sales growth of 0-1% (up from the prior range of -2% to 0%).

• 2024 non-GAAP EPS of $6.30-6.50 (up from the prior range of $6.10-6.40).

At the current share price ($60.00 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 9.4x.
👍️0
abrooklyn abrooklyn 6 월 전
Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Source: PR Newswire (US)
Separation activities and business continuity on track
Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
Generated $355 million in cash from operations; free cash flow1 of $297 million
Raises full-year 2024 organic sales growth and adjusted EPS guidance
ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.

Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)

"As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
👍️ 1
DewDiligence DewDiligence 7 월 전
Activist_investor_builds_stake_in SOLV—(3M’s healthcare spinoff):

https://finance.yahoo.com/news/peltz-trian-building-stake-3m-230900848.html
👍️0
DewDiligence DewDiligence 8 월 전
SOLV 1Q24 Results by Business Segment
%Corp YoY Growth
Segment Sales (const currency)
Medical/surgical* 56% flat
Dental 17% flat
Health-info systems 16% flat
Purification/filtration 12% +7% *Includes components for other companies’ medical devices.
👍️0
DewDiligence DewDiligence 8 월 전
SOLV’s “AI play”—>heath-information systems segment:

https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
👍️0
KingOfSwing...Trading KingOfSwing...Trading 9 월 전
Thank for the excellent post. Very useful.
👍️0
DewDiligence DewDiligence 9 월 전
SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:

https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html

SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.

SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)

The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.

p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
👍️0
Porgie Tirebiter Porgie Tirebiter 11 월 전
All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.

I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
👍️0
DewDiligence DewDiligence 11 월 전
SOLV begins trading on NYSE following completion of spinoff from 3M:

https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
👍️ 1
DewDiligence DewDiligence 11 월 전
SOLV Investor Day CC slides:

https://d1io3yog0oux5.cloudfront.net/_7984eceea22d0dd69e55aae6e648ee7c/3m/db/3194/30840/presentation/Solventum+Investor+Day+3.19.2024.pdf
👍️ 1
DewDiligence DewDiligence 11 월 전
SOLV issues 2024 guidance:

https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html

• Organic revenue growth of -2% to 0%

• Adjusted earnings per share (EPS) of $6.10 to $6.40

• Free cash flow of $700M to $800M
👍️ 1
DewDiligence DewDiligence 12 월 전
Details of 3M’s SOLV spinoff finalized:

https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html

3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.

This is a tax-exempt distribution for US residents.
👍️0
DewDiligence DewDiligence 12 월 전
SOLV sells $6.9B of debt in six tranches:

• $1B of 3yr notes @5.45%

• $1.5B of 5yr notes @5.40%

• $1B of 7yr notes @5.45%

• $1.65B of 10yr notes @5.60%

• $1.25B of 30yr notes @5.90%

• $0.5B of 40yr notes @6.00%

The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.

All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
👍️ 1
DewDiligence DewDiligence 1 년 전
SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
👍️0
DewDiligence DewDiligence 1 년 전
These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:

https://engage.3m.com/purification

https://www.3m.com/3M/en_US/health-information-systems-us/

https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)

https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)

https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
👍️0
DewDiligence DewDiligence 1 년 전
Further details of 3M/SOLV capitalization:

SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)

After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
👍️0
DewDiligence DewDiligence 1 년 전
3M sets 4/1/24 date for Solventum spin-off:

https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
👍️0

최근 히스토리

NYSE
SOLV
Solventum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지